News
MSD Animal Health launches the only registered drug against Cryptosporidiosis
MSD Animal Health launched a unique halofuginone-containing product, the first drug on the market to show specific action against the Cryptosporidium parvum organism, to the veterinary community on Thursday 20 August. Halofuginone has proven success with the reduction in the excretion of oocysts in the environment and reduces the incidence of diarrhea caused by C. […]
MSD Animal Health acquires worldwide rights to VECOXAN®
MSD Animal Health acquires worldwide rights to VECOXAN®